Boulder biotech firm enters reverse merger valued at up to $60 million

In addition to capital, the Boulder company also gains a listing on the Nasdaq.

Source: bizjournals.com Health Care:Biotechnology headlines - June 3, 2019 Category: Biotechnology Authors: Jensen Werley Source Type: news